Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Adequacy of Mental Health Services for HIV-Positive Patients with Depression: Ontario HIV Treatment Network Cohort Study.

Choi SK, Boyle E, Cairney J, Gardner S, Collins EJ, Bacon J, Rourke SB; OHTN Cohort Study Group.

PLoS One. 2016 Jun 9;11(6):e0156652. doi: 10.1371/journal.pone.0156652. eCollection 2016.

2.

Advancing Behavioral HIV Prevention: Adapting an Evidence-Based Intervention for People Living with HIV and Alcohol Use Disorders.

Armstrong ML, LaPlante AM, Altice FL, Copenhaver M, Molina PE.

AIDS Res Treat. 2015;2015:879052. doi: 10.1155/2015/879052. Epub 2015 Dec 1.

3.

Validation of Six Short and Ultra-short Screening Instruments for Depression for People Living with HIV in Ontario: Results from the Ontario HIV Treatment Network Cohort Study.

Choi SK, Boyle E, Burchell AN, Gardner S, Collins E, Grootendorst P, Rourke SB; OHTN Cohort Study Group.

PLoS One. 2015 Nov 13;10(11):e0142706. doi: 10.1371/journal.pone.0142706. eCollection 2015.

4.

Paths to improving engagement among racial and ethnic minorities in addiction health services.

Guerrero EG, Fenwick K, Kong Y, Grella C, D'Aunno T.

Subst Abuse Treat Prev Policy. 2015 Oct 26;10:40. doi: 10.1186/s13011-015-0036-z.

5.

The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial.

Pence BW, Gaynes BN, Adams JL, Thielman NM, Heine AD, Mugavero MJ, McGuinness T, Raper JL, Willig JH, Shirey KG, Ogle M, Turner EL, Quinlivan EB.

AIDS. 2015 Sep 24;29(15):1975-86. doi: 10.1097/QAD.0000000000000797.

PMID:
26134881
6.

Attitudes and Training Needs of New England HIV Care and Addiction Treatment Providers: Opportunities for Better Integration of HIV and Alcohol Treatment Services.

Montague BT, Kahler CW, Colby SM, McHugh RK, Squires D, Fitzgerald B, Operario D, Gallagher D, Monti PM, Mayer KH.

Addict Disord Their Treat. 2015 Mar;14(1):16-28.

7.

Reliability and validity of depression assessment among persons with HIV in sub-Saharan Africa: systematic review and meta-analysis.

Tsai AC.

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):503-11. doi: 10.1097/QAI.0000000000000210. Review.

8.

Substance use in older HIV-infected patients.

Edelman EJ, Tetrault JM, Fiellin DA.

Curr Opin HIV AIDS. 2014 Jul;9(4):317-24. doi: 10.1097/COH.0000000000000069. Review.

9.

The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk.

Ferrara M, Umlauf A, Sanders C, Meyer JM, Allen McCutchan J, Duarte N, Hampton Atkinson J, Grant I, Ellis RJ; CHARTER Group.

Psychiatry Res. 2014 Aug 15;218(1-2):201-8. doi: 10.1016/j.psychres.2014.04.015. Epub 2014 Apr 18.

10.

Patient perspectives of an integrated program of medical care and substance use treatment.

Drainoni ML, Farrell C, Sorensen-Alawad A, Palmisano JN, Chaisson C, Walley AY.

AIDS Patient Care STDS. 2014 Feb;28(2):71-81. doi: 10.1089/apc.2013.0179. Epub 2014 Jan 15.

11.

HIV-related stigma among African-American youth in the Northeast and Southeast US.

Kerr JC, Valois RF, Diclemente RJ, Fletcher F, Carey MP, Romer D, Vanable PA, Farber N.

AIDS Behav. 2014 Jun;18(6):1063-7. doi: 10.1007/s10461-013-0687-6.

12.

Do HIV-positive women receive depression treatment that meets best practice guidelines?

Cook JA, Burke-Miller JK, Grey DD, Cocohoba J, Liu C, Schwartz RM, Golub ET, Anastos K, Steigman PJ, Cohen MH.

AIDS Behav. 2014 Jun;18(6):1094-102. doi: 10.1007/s10461-013-0679-6.

13.

Health correlates of co-occurring substance use for women with HIV in cocaine use recovery.

McCabe BE, Feaster DJ, Mitrani VB.

Addict Behav. 2014 Mar;39(3):725-8. doi: 10.1016/j.addbeh.2013.11.026. Epub 2013 Dec 3.

14.

Substance abuse treatment in persons with HIV/AIDS: challenges in managing triple diagnosis.

Durvasula R, Miller TR.

Behav Med. 2014;40(2):43-52. doi: 10.1080/08964289.2013.866540. Review.

15.

Factors associated with treatment initiation for psychiatric and substance use disorders among persons with HIV.

Satre DD, DeLorenze GN, Quesenberry CP, Tsai A, Weisner C.

Psychiatr Serv. 2013 Aug 1;64(8):745-53. doi: 10.1176/appi.ps.201200064.

16.

HIV/AIDS, comorbidity, and alcohol: can we make a difference?

Justice A, Sullivan L, Fiellin D; Veterans Aging Cohort Study Project Team.

Alcohol Res Health. 2010;33(3):258-66. Review.

17.

Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathies.

Harrison T, Miyahara S, Lee A, Evans S, Bastow B, Simpson D, Gilron I, Dworkin R, Daar ES, Wieclaw L, Clifford DB; ACTG A5252 Team.

Pain Med. 2013 Jul;14(7):1039-47. doi: 10.1111/pme.12084. Epub 2013 Apr 8.

18.

Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study.

Byrd DA, Robinson-Papp J, Mindt MR, Mintz L, Elliott K, Lighty Q, Morgello S; Manhattan HIV Brain Bank.

J Int Neuropsychol Soc. 2013 Apr;19(4):463-73. doi: 10.1017/S1355617712001634. Epub 2013 Feb 28.

19.

Documentation of psychiatric disorders and related factors in a large sample population of HIV-positive patients in California.

Parhami I, Fong TW, Siani A, Carlotti C, Khanlou H.

AIDS Behav. 2013 Oct;17(8):2792-801. doi: 10.1007/s10461-012-0386-8.

20.

In-home mental health treatment for individuals with HIV.

Reif SS, Pence BW, LeGrand S, Wilson ES, Swartz M, Ellington T, Whetten K.

AIDS Patient Care STDS. 2012 Nov;26(11):655-61. doi: 10.1089/apc.2012.0242. Epub 2012 Oct 10.

Items per page

Supplemental Content

Write to the Help Desk